Home » Topics » Regulatory » Patents

Patents
RSS

Novel antihypertensives imparted by Novartis and NitroMed

Oct. 11, 2006

HIV reverse transcriptase inhibitors emerge from Roche R&D

Oct. 10, 2006

Recent patents report new treatments for depression, psychosis, sleep disorders, etc.

Oct. 10, 2006

Recent patents report novel treatment strategies for respiratory disorders

Oct. 10, 2006

New treatment options for cancer covered in recent patent literature

Oct. 9, 2006

Abbott patents novel RNA-directed RNA polymerase inhibitors

Oct. 9, 2006

Recent patents disclose novel antiinfective agents

Oct. 9, 2006

Recent patents impart new agents for atherosclerosis, hypertension, etc.

Oct. 6, 2006

Development of obestatin peptide derivatives reported by Leland Stanford Junior University

Oct. 6, 2006

Tokyo University of Science patent discloses novel agents for preventing transplant rejection

Oct. 6, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...